The vertebrate segmentation clock and its role in skeletal birth defects.
The segmental structure of the vertebrate body plan is most evident in the axial skeleton. The regulated generation of somites, a process called somitogenesis, underlies the vertebrate body plan and is crucial for proper skeletal development. A genetic clock regulates this process, controlling the timing of somite development. Molecular evidence for the existence of the segmentation clock was first described in the expression of Notch signaling pathway members, several of which are expressed in a cyclic fashion in the presomitic mesoderm (PSM). The Wnt and fibroblast growth factor (FGF) pathways have also recently been linked to the segmentation clock, suggesting that a complex, interconnected network of three signaling pathways regulates the timing of somitogenesis. Mutations in genes that have been linked to the clock frequently cause abnormal segmentation in model organisms. Additionally, at least two human disorders, spondylocostal dysostosis (SCDO) and Alagille syndrome (AGS), are caused by mutations in Notch pathway genes and exhibit vertebral column defects, suggesting that mutations that disrupt segmentation clock function in humans can cause congenital skeletal defects. Thus, it is clear that the correct, cyclic function of the Notch pathway within the vertebrate segmentation clock is essential for proper somitogenesis. In the future, with a large number of additional cyclic genes recently identified, the complex interactions between the various signaling pathways making up the segmentation clock will be elucidated and refined.
Shifley
Emily T
ET
Department of Molecular Genetics, The Ohio State University, Columbus, Ohio 43210, USA.
Cole
Susan E
SE
D016738:Alagille Syndrome / Q000209:etiology / Q000235:genetics; D000818:Animals; D001683:Biological Clocks / Q000235:genetics*; D019521:Body Patterning / Q000235:genetics; D001848:Bone Diseases, Developmental / Q000209:etiology* / Q000235:genetics; D001842:Bone and Bones / Q000002:abnormalities*; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D051881:Receptor, Notch1 / Q000235:genetics / Q000378:metabolism; D051880:Receptors, Notch / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D019170:Somites; D051153:Wnt Proteins / Q000235:genetics / Q000378:metabolism
C497761:NOTCH1 protein, human; D051881:Receptor, Notch1; D051880:Receptors, Notch; D051153:Wnt Proteins; D005346:Fibroblast Growth Factors